BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17876780)

  • 1. A multiphase microscopic diffusion model for stratum corneum permeability. II. Estimation of physicochemical parameters, and application to a large permeability database.
    Wang TF; Kasting GB; Nitsche JM
    J Pharm Sci; 2007 Nov; 96(11):3024-51. PubMed ID: 17876780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiphase microscopic diffusion model for stratum corneum permeability. I. Formulation, solution, and illustrative results for representative compounds.
    Wang TF; Kasting GB; Nitsche JM
    J Pharm Sci; 2006 Mar; 95(3):620-48. PubMed ID: 16447176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis/dermis of rat skin.
    Yamaguchi K; Mitsui T; Aso Y; Sugibayashi K
    J Pharm Sci; 2008 Oct; 97(10):4391-403. PubMed ID: 18228598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kinetics.
    Anissimov YG; Roberts MS
    J Pharm Sci; 2009 Feb; 98(2):772-81. PubMed ID: 18543296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism.
    Johnson ME; Blankschtein D; Langer R
    J Pharm Sci; 1997 Oct; 86(10):1162-72. PubMed ID: 9344175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Sensitive Are Transdermal Transport Predictions by Microscopic Stratum Corneum Models to Geometric and Transport Parameter Input?
    Wen J; Koo SM; Lape N
    J Pharm Sci; 2018 Feb; 107(2):612-623. PubMed ID: 28989022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-principles, structure-based transdermal transport model to evaluate lipid partition and diffusion coefficients of hydrophobic permeants solely from stratum corneum permeation experiments.
    Kushner J; Deen W; Blankschtein D; Langer R
    J Pharm Sci; 2007 Dec; 96(12):3236-51. PubMed ID: 17887175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-silico model of skin penetration based on experimentally determined input parameters. Part I: experimental determination of partition and diffusion coefficients.
    Hansen S; Henning A; Naegel A; Heisig M; Wittum G; Neumann D; Kostka KH; Zbytovska J; Lehr CM; Schaefer UF
    Eur J Pharm Biopharm; 2008 Feb; 68(2):352-67. PubMed ID: 17587558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non steady-state descriptions of drug permeation through stratum corneum. I. The biphasic brick-and-mortar model.
    Heisig M; Lieckfeldt R; Wittum G; Mazurkevich G; Lee G
    Pharm Res; 1996 Mar; 13(3):421-6. PubMed ID: 8692735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcellular route of diffusion through stratum corneum: results from finite element models.
    Barbero AM; Frasch HF
    J Pharm Sci; 2006 Oct; 95(10):2186-94. PubMed ID: 16883560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of steady-state skin permeabilities of polar and nonpolar permeants across excised pig skin based on measurements of transient diffusion: characterization of hydration effects on the skin porous pathway.
    Tang H; Blankschtein D; Langer R
    J Pharm Sci; 2002 Aug; 91(8):1891-907. PubMed ID: 12115816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A theoretical analysis of permeation of small hydrophobic solutes across the stratum corneum based on Scaled Particle Theory.
    Mitragotri S
    J Pharm Sci; 2002 Mar; 91(3):744-52. PubMed ID: 11920759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state flux and lag time in the stratum corneum lipid pathway: results from finite element models.
    Frasch HF; Barbero AM
    J Pharm Sci; 2003 Nov; 92(11):2196-207. PubMed ID: 14603505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Dynamics as a tool for in silico screening of skin permeability.
    Rocco P; Cilurzo F; Minghetti P; Vistoli G; Pedretti A
    Eur J Pharm Sci; 2017 Aug; 106():328-335. PubMed ID: 28627472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-phase analysis of solute partitioning into the stratum corneum.
    Nitsche JM; Wang TF; Kasting GB
    J Pharm Sci; 2006 Mar; 95(3):649-66. PubMed ID: 16432875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties.
    Akomeah FK; Martin GP; Brown MB
    J Pharm Sci; 2007 Apr; 96(4):824-34. PubMed ID: 17177207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure.
    Dancik Y; Miller MA; Jaworska J; Kasting GB
    Adv Drug Deliv Rev; 2013 Feb; 65(2):221-36. PubMed ID: 22285584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Composite Model for the Transport of Hydrophilic and Lipophilic Compounds Across the Skin: Steady-State Behavior.
    Kasting GB; Miller MA; LaCount TD; Jaworska J
    J Pharm Sci; 2019 Jan; 108(1):337-349. PubMed ID: 30244009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A random walk model of skin permeation.
    Frasch HF
    Risk Anal; 2002 Apr; 22(2):265-76. PubMed ID: 12022675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.